Skip to main content
Premium Trial:

Request an Annual Quote

Billion-Dollar Diversity Initiative

The Howard Hughes Medical Institute is launching a billion-dollar initiative aimed at boosting the diversity of the scientific workforce, the Scientist says.

The approximately $1.5 billion initiative, dubbed the Freeman Hrabowski Scholars Program, will support 150 early career faculty members in the basic biomedical sciences who are committed to promoting diversity, equity, and inclusion in science. According to HHMI, 30 faculty members will be added to the program every other year for a term of five years, with the possibility of one renewal. The scholars, it says, may receive up to $8.6 million over 10 years. It adds that it is currently accepting applications for 2023.

"Often when people talk about diversity, equity, and inclusion, it's because they're worried about violence in the streets or they realize it's the right thing to do to give everybody opportunities," Freeman Hrabowski, the president of the University of Maryland Baltimore County and after whom the program is named, tells Inside Higher Ed. Hrabowski, it adds, is known for his commitment to diversity.

"But this signal from Howard Hughes Medical Institute is that bringing more people into science and medicine is crucial — it's critical to the future of humankind," he adds there.

Filed under

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.